Atorvastatin Tablets IP 10 mg Exporter

Atorvastatin Tablets IP 10 mg Exporter in India – Healthy Inc

Atorvastatin Tablets IP 10 mg Exporter product packaging

Atorvastatin Tablets IP 10 mg | Exporter

Product image for Atorvastatin Tablets IP 10 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic NameAtorvastatin
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP
Product TypeTablet
CategoryLipid-Lowering drugs
SubcategoryLipid-Lowering drugs
Active IngredientAtorvastatin
Strength10 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryLipid-Lowering drugs

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for Atorvastatin Tablets IP 10 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. Treatment of primary hypercholesterolemia and combined (mixed) dyslipidemia. 2. Reduction of myocardial infarction, stroke, and arterial revascularization risks in patients with coronary heart disease.
Full Description

Healthy Inc invites international procurement enquiries for Atorvastatin Tablets IP 10 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic nameAtorvastatin
CompositionAtorvastatin
Strength10 mg
CategoryLipid-Lowering drugs
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For Atorvastatin Tablets IP 10 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally once daily in the evening or at bedtime, with or without food. Maintain a standard cholesterol-lowering diet throughout the therapeutic duration.
Side EffectsCommon: Myalgia (muscle ache), headache, mild dyspepsia, nausea, constipation. Uncommon: Asthenia, insomnia, abdominal pain, mild transaminase elevation. Rare: Myopathy, rhabdomyolysis with acute renal failure, immune-mediated necrotizing myopathy.
Warnings and PrecautionsMyopathy Risk: Immediately report unexplained muscle pain, tenderness, or weakness, especially if accompanied by dark urine or fever. Hepatic Function: Perform baseline liver function tests before starting therapy and clinically thereafter. Avoid excessive alcohol consumption.
Contraindications1. Known hypersensitivity to Atorvastatin or formulation components.
2. Active liver disease or unexplained, persistent transaminase elevations.
3. Pregnancy, planned pregnancy, and breastfeeding.
Drug Interactions1. CYP3A4 Inhibitors (Ketoconazole, Clarithromycin, Protease Inhibitors): Markedly increase statin plasma levels, elevating rhabdomyolysis risk.
2. Fibrates & Niacin: Increased risk of skeletal muscle toxicity when co-administered.
3. Grapefruit Juice: Substantial intake increases systemic drug bioavailability.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for Atorvastatin Tablets IP 10 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for Atorvastatin Tablets IP 10 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for Atorvastatin Tablets IP 10 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for Atorvastatin Tablets IP 10 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for Atorvastatin Tablets IP 10 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Tags

Atorvastatin Tablets IP 10 mg ExporterAtorvastatin 10 mgRegulatory Dossiers & International ShippingHealthy Inc

Product Hashtags

#Atorvastatin#Exporter#PharmaB2B

Related Products

Related Posts